$369.00 – $1,999.00
The drug Kovaltry is intended for the treatment of hemophilia type A in patients of all age groups. The drug is an unmodified recombinant blood coagulation factor VIII, for the production of which no components of animal or human origin are used.
Active substance:
Prescription medicine.
| Дозировка | 500 IU, 1000 IU, 2000 IU |
|---|
